KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Goodwill Amortization of Goodwill Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Cvs Health (CVS) Net Cash Flow (2016 - 2025)

Cvs Health's Net Cash Flow history spans 17 years, with the latest figure at -$640.0 million for Q4 2025.

For the quarter ending Q4 2025, Net Cash Flow fell 136.7% year-over-year to -$640.0 million, compared with a TTM value of -$172.0 million through Dec 2025, down 147.91%, and an annual FY2025 reading of -$172.0 million, down 147.91% over the prior year.
Net Cash Flow for Q4 2025 was -$640.0 million at Cvs Health, up from -$2.7 billion in the prior quarter.
The five-year high for Net Cash Flow was $5.1 billion in Q3 2022, with the low at -$5.7 billion in Q3 2024.
Average Net Cash Flow over 5 years is -$116.6 million, with a median of $251.5 million recorded in 2021.
Year-over-year, Net Cash Flow crashed 1120.06% in 2022 and then surged 427.66% in 2024.
Tracing CVS's Net Cash Flow over 5 years: stood at -$349.0 million in 2021, then crashed by 1120.06% to -$4.3 billion in 2022, then dropped by 13.9% to -$4.9 billion in 2023, then surged by 135.96% to $1.7 billion in 2024, then plummeted by 136.7% to -$640.0 million in 2025.
Per Business Quant, the three most recent readings for CVS's Net Cash Flow are -$640.0 million (Q4 2025), -$2.7 billion (Q3 2025), and $1.7 billion (Q2 2025).